The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase 2 multicenter study of the EZH2 inhibitor tazemetostat in adults with INI1 negative epithelioid sarcoma (NCT02601950).
 
Mrinal M. Gounder
Honoraria - Amgen; Daiichi Sankyo; Karyopharm Therapeutics; TRACON Pharma
Consulting or Advisory Role - Amgen; Daiichi Sankyo; Epizyme; Karyopharm Therapeutics
Speakers' Bureau - Amgen
Travel, Accommodations, Expenses - Amgen; Daiichi Sankyo; Karyopharm Therapeutics
 
Silvia Stacchiotti
Honoraria - Lilly; PharmaMar; Takeda
Consulting or Advisory Role - Bayer; Daiichi Sankyo; Karyopharm Therapeutics; Lilly; PharmaMar; Plexxikon
Research Funding - Amgen (Inst); Bayer (Inst); Daiichi Sankyo (Inst); Epizyme (Inst); Lilly (Inst); Novartis (Inst); Pfizer (Inst); PharmaMar (Inst)
Travel, Accommodations, Expenses - PharmaMar
 
Patrick Schöffski
Honoraria - Daiichi Sankyo; Eisai; Lilly; Medpace; Novartis; Swedish Orphan Biovitrum
Consulting or Advisory Role - 6th Element Capital; Adaptimmune; Amcure; AstraZeneca; Bayer; Blueprint Medicines; Boehringer Ingelheim; Bristol-Myers Squibb; Cristal Therapeutics; Daiichi Sankyo; Eisai; Epizyme; Ipsen; Lilly; Loxo; Medpace; Nektar; Novartis; Philogen; Pique; Plexxikon; Sanofi
Speakers' Bureau - Bayer; Eisai; GlaxoSmithKline; Lilly; Novartis; PharmaMar; Swedish Orphan Biovitrum
Research Funding - Bayer; Blueprint Medicines; Cobiores nv; Exelixis; GlaxoSmithKline; Novartis; Plexxikon
Travel, Accommodations, Expenses - 6th Element Capital; Adaptimmune; Amcure; AstraZeneca; Bayer; Blueprint Medicines; Boehringer Ingelheim; Bristol-Myers Squibb; Cristal Therapeutics; Daiichi Sankyo; Eisai; Epizyme; Ipsen; Lilly; Loxo; Medpace; Nektar; Novartis; PharmaMar; Philogen; Pique; Plexxikon; Sanofi; Swedish Orphan Biovitrum
 
Steven Attia
Consulting or Advisory Role - EMD Serono; Karyopharm Therapeutics
Research Funding - AB Science (Inst); Bayer (Inst); Bayer (Inst); CytRx Corporation (Inst); Daiichi Sankyo (Inst); Epizyme (Inst); Immune Design (Inst); Karyopharm Therapeutics (Inst); Lilly (Inst); Lilly (Inst); Morphotek (Inst); Novartis (Inst); Novartis (Inst); Threshold Pharmaceuticals (Inst); TRACON Pharma (Inst); ZIOPHARM Oncology (Inst)
 
Antoine Italiano
No Relationships to Disclose
 
Robin Jones
Consulting or Advisory Role - Adaptimmune; Bayer; Eisai; Immune Design; Lilly; Merck; PharmaMar
 
George D. Demetri
Leadership - Blueprint Medicines
Stock and Other Ownership Interests - Bessor Pharma; Blueprint Medicines; Caris Life Sciences; Champions Oncology; G1 Therapeutics; N-of-One
Consulting or Advisory Role - Adaptimmune; Bayer; Blueprint Medicines; Caris Life Sciences; Daiichi Sankyo; Eisai; EMD Serono; G1 Therapeutics; Genocea Biosciences; Janssen Oncology; Kolltan Pharmaceuticals; Kyocera; Lilly; Nektar; Novartis; Pfizer; PharmaMar; Polaris; Sanofi; WIRB-Copernicus Group; ZIOPHARM Oncology
Research Funding - Abbvie (Inst); Janssen Oncology (Inst)
Patents, Royalties, Other Intellectual Property - Patent on use of imatinib for GIST, receive minor royalty payment from Dana-Farber after license between Dana-Farber and Novartis
 
Stephen Blakemore
Employment - Epizyme
Stock and Other Ownership Interests - Epizyme
 
Alicia Clawson
Employment - Epizyme
Stock and Other Ownership Interests - Epizyme
 
Scott Daigle
Employment - Epizyme
Stock and Other Ownership Interests - Epizyme
Patents, Royalties, Other Intellectual Property - Patents Relating to Pinometostat methods of use including combination and indications
Travel, Accommodations, Expenses - Epizyme
 
Scott Ribich
Employment - Epizyme
Stock and Other Ownership Interests - Epizyme
Research Funding - Epizyme
Patents, Royalties, Other Intellectual Property - Epizyme
 
Maria Roche
Employment - Epizyme
Stock and Other Ownership Interests - Epizyme
 
Jill Rodstrom
Employment - Epizyme
 
Peter T.C. Ho
Employment - Epizyme
Leadership - Epizyme
Stock and Other Ownership Interests - BeiGene; Epizyme; Johnson & Johnson
Consulting or Advisory Role - Lilly Asia Ventures
 
Gregory Michael Cote
Consulting or Advisory Role - Advance Medical; InfiniteMD
Research Funding - Agios (Inst); Amgen (Inst); Boston Biomedical (Inst); Epizyme (Inst); Macrogenics (Inst); Otsuka (Inst); PharmaMar (Inst)